P. Fratino

951 total citations
31 papers, 687 citations indexed

About

P. Fratino is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P. Fratino has authored 31 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P. Fratino's work include Lipoproteins and Cardiovascular Health (6 papers), Heart Rate Variability and Autonomic Control (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). P. Fratino is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Heart Rate Variability and Autonomic Control (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). P. Fratino collaborates with scholars based in Italy, Netherlands and Finland. P. Fratino's co-authors include G Finardi, Luciano Bernardi, A Calciati, Luigi Ricordi, Pier Luigi Soldà, P. Lazzari, Carmine Gazzaruso, Pasquale De Cata, Adriana Garzaniti and Ezio Faglia and has published in prestigious journals such as Circulation, Atherosclerosis and Journal of Internal Medicine.

In The Last Decade

P. Fratino

30 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Fratino Italy 10 308 291 208 84 81 31 687
Luis Eduardo Juárez‐Orozco Netherlands 16 316 1.0× 487 1.7× 103 0.5× 167 2.0× 75 0.9× 60 1.3k
Antti Loimaala Finland 17 227 0.7× 447 1.5× 155 0.7× 103 1.2× 114 1.4× 30 888
John A. Zelano United States 13 207 0.7× 131 0.5× 53 0.3× 74 0.9× 52 0.6× 23 492
Kathleen M. Weil United States 8 272 0.9× 242 0.8× 92 0.4× 49 0.6× 42 0.5× 11 633
S. P. Sady United States 13 159 0.5× 178 0.6× 122 0.6× 139 1.7× 46 0.6× 23 906
Mohammed Yousufuddin United States 13 172 0.6× 460 1.6× 44 0.2× 49 0.6× 81 1.0× 50 874
Andrea J. Carpenter United States 16 426 1.4× 187 0.6× 175 0.8× 95 1.1× 74 0.9× 30 1.0k
Dennis J. Morgan United States 8 155 0.5× 843 2.9× 90 0.4× 153 1.8× 115 1.4× 11 1.0k
Krishna Prasad India 15 257 0.8× 1.4k 4.8× 106 0.5× 181 2.2× 109 1.3× 61 1.6k
Karl‐Heinz Labs Switzerland 16 484 1.6× 154 0.5× 47 0.2× 21 0.3× 201 2.5× 26 757

Countries citing papers authored by P. Fratino

Since Specialization
Citations

This map shows the geographic impact of P. Fratino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Fratino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Fratino more than expected).

Fields of papers citing papers by P. Fratino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Fratino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Fratino. The network helps show where P. Fratino may publish in the future.

Co-authorship network of co-authors of P. Fratino

This figure shows the co-authorship network connecting the top 25 collaborators of P. Fratino. A scholar is included among the top collaborators of P. Fratino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Fratino. P. Fratino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bianchi, Luca, Camillo Porta, Andrea Rinaldi, et al.. (2017). Integrated cardiovascular/respiratory control in type 1 diabetes evidences functional imbalance: Possible role of hypoxia. International Journal of Cardiology. 244. 254–259. 7 indexed citations
2.
Sacchi, Lucia, et al.. (2010). Mining Health Care Administrative Data with Temporal Association Rules on Hybrid Events. Methods of Information in Medicine. 50(2). 166–179. 27 indexed citations
4.
Lucioni, Carlo, et al.. (2006). Uno studio di drug utilisation delle statine nella recente prassi terapeutica italiana. 8(1). 3–17. 4 indexed citations
5.
Stefanelli, Mario, Pietro Ferrari, Pasquale De Cata, et al.. (2006). The M2DM Project. Methods of Information in Medicine. 45(1). 79–84. 33 indexed citations
6.
Gazzaruso, Carmine, Raffaele Bruno, Arturo Pujia, et al.. (2005). Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients. International Journal of Cardiology. 108(3). 354–358. 26 indexed citations
7.
Faglia, Ezio, Manuela Mantero, Maurizio Caminiti, et al.. (2002). Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. Journal of Internal Medicine. 252(3). 225–232. 186 indexed citations
8.
Gazzaruso, Carmine, Adriana Garzaniti, Colomba Falcone, et al.. (2001). Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non‐diabetic subjects. Diabetic Medicine. 18(7). 589–594. 27 indexed citations
9.
Gazzaruso, Carmine, Adriana Garzaniti, Giuseppe d’Annunzio, et al.. (1998). Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetologica. 35(1). 13–18. 18 indexed citations
10.
Gazzaruso, Carmine, Adriana Garzaniti, Graziella Bonetti, et al.. (1998). Apolipoprotein(a) Phenotypes and Their Predictive Value for Coronary Heart Disease: Identification of an Operative Cut-Off of Apolipoprotein(a) Polymorphism. European Journal of Cardiovascular Prevention & Rehabilitation. 5(1). 37–42. 15 indexed citations
11.
Gazzaruso, Carmine, Adriana Garzaniti, Graziella Bonetti, et al.. (1996). Lipoprotein(a) and proliferative diabetic retinopathy in type II diabetes mellitus : A role for isoforms with low molecular weight. 9(3). 129–137. 6 indexed citations
12.
Geroldi, Diego, Carmine Gazzaruso, Adriana Garzaniti, et al.. (1994). Apo(a) isoforms: a genetic marker for progression of coronary atherosclerosis. Atherosclerosis. 109(1-2). 283–283. 1 indexed citations
13.
Grandi, Anna Maria, Luigi Ricordi, Marco Rossi, et al.. (1992). Noninvasive assessment of the relationship between cardiac and autonomic function in diabetes.. PubMed. 47(1). 77–85. 2 indexed citations
14.
Montecucco, Carlomaurizio, et al.. (1990). Serum osteocalcin (bone gla-protein) and bone mineral content in non-insulin dependent diabetes. 3(4). 311–316. 5 indexed citations
15.
Pacchiarini, L, et al.. (1989). Fibrinopeptide A Levels in Patients with Acute Ischaemic Heart Disease. Pathophysiology of Haemostasis and Thrombosis. 19(3). 147–151. 5 indexed citations
16.
Ricordi, Luigi, et al.. (1989). Hypertension in diabetes: an additional factor determining autonomic neuropathy?. 2(4). 269–275. 7 indexed citations
17.
Fratino, P., et al.. (1980). [Glucose and insulin in psoriasis. Role of obesity and genetic considerations in diabetes].. PubMed. 71(44). 3265–3265. 1 indexed citations
18.
Fratino, P., et al.. (1979). Insulin receptors in psoriasis.. PubMed. 87. 38–40. 4 indexed citations
19.
Fratino, P., et al.. (1977). Psoriasis and insulin secretion. Archives of Dermatological Research. 257(3). 239–246. 7 indexed citations
20.
Specchia, Giorgina, et al.. (1967). [Variations in glucide assimilation during the day. I. Changes in the normal subject and in subjects with essential obesity].. PubMed. 43(24). 1891–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026